Sugammadex Dosing: Anaesthesiologist Clinical Perception Versus Quantitative Monitoring

CompletedOBSERVATIONAL
Enrollment

66

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Neuromuscular BlockadeAnesthesiaTOFCurarization, Postoperative Residual
Interventions
OTHER

Dose of sugammadex according to SSD and QSD

At the time of pharmacologic reversal of the NMB, both the SSD and QSD, according to portuguese guidelines on the management of the NMB, were recorded. The QSD was then administered to the patient. The SSD was considered appropriate if it was within 10% of the recommended dose for the given depth of NMB, as measured by TOFscan® monitor. The results were analyzed descriptively.

Trial Locations (1)

9500-370

Hospital do Divino Espírito Santo, Ponta Delgada

All Listed Sponsors
lead

Hospital do Divino Espírito Santo de Ponta Delgada

OTHER

NCT04762420 - Sugammadex Dosing: Anaesthesiologist Clinical Perception Versus Quantitative Monitoring | Biotech Hunter | Biotech Hunter